Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amphastar Eyes Sun Pharma Showdown With US Ganirelix Approval
Other ANDA Sponsor Sun Pharma Had Issued Recall Last Year
Apr 08 2022
•
By
Dean Rudge
Amphastar has its eye on a US ganirelix acetate launch • Source: Antony McAulay / Alamy Stock Photo
More from Products
More from Generics Bulletin